Cargando…
Suppression of STN1 enhances the cytotoxicity of chemotherapeutic agents in cancer cells by elevating DNA damage
DNA damage-inducing agents are among the most effective treatment regimens in clinical chemotherapy. However, drug resistance and severe side effects caused by these agents greatly limit their efficacy. Sensitizing malignant cells to chemotherapeutic agents has long been a goal of chemotherapy. In t...
Autores principales: | Zhou, Qing, Chai, Weihang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950739/ https://www.ncbi.nlm.nih.gov/pubmed/27446354 http://dx.doi.org/10.3892/ol.2016.4676 |
Ejemplares similares
-
Deficiency in mammalian STN1 promotes colon cancer development via inhibiting DNA repair
por: Nguyen, Dinh Duc, et al.
Publicado: (2023) -
The Intrinsically Disordered Region in the Human STN1 OB-Fold Domain Is Important for Protecting Genome Stability
por: Chai, Weihang, et al.
Publicado: (2021) -
MMSET/WHSC1 enhances DNA damage repair leading to an increase in resistance to chemotherapeutic agents
por: Shah, Mrinal Y., et al.
Publicado: (2016) -
The major thylakoid protein kinases STN7 and STN8 revisited: effects of altered STN8 levels and regulatory specificities of the STN kinases
por: Wunder, Tobias, et al.
Publicado: (2013) -
Bone Marrow Osteoblast Damage by Chemotherapeutic Agents
por: Rellick, Stephanie L., et al.
Publicado: (2012)